Ionis’ rare neurology drug approved; Pfizer inks an ADC deal
RegulatoryapprovedZanvastroPositive
AI Analysis
Summary
Ionis' Zanvastro became the first approved treatment for Alexander disease, while Pfizer entered an antibody-drug conjugate (ADC) deal. An immune system specialist reported positive results and a cell therapy developer announced layoffs.
Outcome Details
First approved medicine for Alexander disease
Importance:8/10
Sentiment:
0.80
FDA approvalrare diseaseneurologyacquisitionADC dealpositive results
Read the original article
Published by BioPharma Dive on September 4, 2026 1:00 PM